The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis

BMC Gastroenterology

Volumn 5, Issue , 2005, Pages

  ter Borg, Peter C J ^a   Fekkes, Durk ^a   Vrolijk, Jan Maarten ^a   van Buuren, Henk R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ISOLEUCINE; LEUCINE; PHENYLALANINE; TRYPTOPHAN; TYROSINE; VALINE; AMINO ACID; BIOLOGICAL MARKER;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FATIGUE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTHROMBIN TIME; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; VISUAL ANALOG SCALE; BILIARY CIRRHOSIS; BLOOD; MIDDLE AGED; OSMOLARITY; PATHOPHYSIOLOGY; SCLEROSING CHOLANGITIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AMINO ACIDS; BIOLOGICAL MARKERS; CHOLANGITIS, SCLEROSING; FATIGUE; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TYROSINE;

EID: 25444433116     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-5-11     Document Type: Article

References (25)

1. Angulo P, Lindor KD: Primary sclerosing cholangitis. Hepatology 1999, 30:325-332.
2. Neuberger J: Primary biliary cirrhosis. Lancet 1997, 350:875-879.
3. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J: Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000, 95:760-767.
4. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ: Fatigue in primary biliary cirrhosis. Gut 1998, 43:705-710.
5. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985, 88:108-114.
6. Prince MI, James OF, Holland NP, Jones DE: Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000, 32:368-373.
7. McGuire J, Ross GL, Price H, Mortensen N, Evans J, Castell LM: Biochemical markers for post-operative fatigue after major surgery. Brain Res Bull 2003, 60:125-130.
8. Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP: Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin Sci (Lond) 2003, 105:213-218.
9. Butterworth RF: Neuroactive amino acids in hepatic encephalopathy. Metab Brain Dis 1996, 11:165-173.
10. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18 Suppl 1:S79-83.
11. Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
12. Fekkes D, van Dalen A, Edelman M, Voskuilen A: Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. J Chromatogr B Biomed Appl 1995, 669:177-186.
13. Morgan MY, Marshall AW, Milsom JP, Sherlock S: Plasma amino-acid patterns in liver disease. Gut 1982, 23:362-370.
14. Morgan MY, Milsom JP, Sherlock S: Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 1978, 19:1068-1073.
15. Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 1978, 187:343-350.
16. Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, Jhaver K, Baban B: Tryptophan catabolism and T cell responses. Adv Exp Med Biol 2003, 527:27-35.
17. Goldblatt J, James OF, Jones DE: Grip strength and subjective fatigue in patients with primary biliary cirrhosis. Jama 2001, 285:2196-2197.
18. Watson JP, Jones DE, James OF, Cann PA, Bramble MG: Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study. J Gastroenterol Hepatol 1999, 14:1034-1040.
19. Prince MI, Mitchison HC, Ashley D, Burke DA, Edwards N, Bramble MG, James OF, Jones DE: Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther 2003, 17:137-143.
20. Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, Psych C, Papatheodorou G, Zipursky RB: A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology 2001, 25:213-223.
21. Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, Kopala L, Rui Q, Zipursky RB, Kapur S: Effects of catecholamine depletion on D(2) receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav 2003, 74:425-432.
22. Avraham Y, Hao S, Mendelson S, Berry EM: Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med Sci Sports Exerc 2001, 33:2104-2110.
23. Owasoyo JO, Neri DF, Lamberth JG: Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat Space Environ Med 1992, 63:364-369.
24. Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ: Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull 1999, 48:203-209.
25. Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, Allsop JM, Hajnal JV, Thomas HC, Bassendine M, Jones DE, Taylor-Robinson SD: Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004, 53:587-592.